medall.group23, Author at Med Alliance Group

Home
/
Author: medall.group23
/
Page 22

February 23 Webinar: Clinical Applications for the Abdominal Aortic & Junctional Tourniquet – Stabilized (AAJT-S)

Register today for the Compression Works webinar at 11am CST on February 23 to discover the clinical applications for the AAJT-S.

MED Alliance Group is Pleased to Partner with Compression Works

MED Alliance Group welcomes Compression Works, the manufacturer of the Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S) medical device.

How to Place an Order

You may place an order for one of the many products distributed by MED Alliance via one of the following methods.

Intellego Technologies Partners with MED Alliance International

Intellego Technologies is partnering with MED Alliance International to provide logistical and operational support to deliver UVC Dosimeters to clinical customers in the U.S. and Canada.

Preventing Pediatric Intubations with the Right NIV interface

The Pedi-Fit Full-Face and Nasal Masks are designed to comfortably fit pediatric patients for NIV success, preventing intubations.

Four Essentials You Need to Know About EMS Capnography

Capnography is an essential monitoring technique for cardiac patients requiring resuscitation and respiratory support. Here are four things to remember when monitoring EtCO2 in prehospital settings.

High-Performing Respiratory Care Devices Specially Designed for Patient and Clinician Safety

Solutions in Critical Care offers high-performing respiratory therapy devices with infection control features that are critical to keeping patients and clinicians safe.

MaxPlus Blood Cooler Enables EMS to Carry Blood and Increase Trauma Patient Survival Rates

With increasing evidence suggesting that the survival rate of severely injured patients increases when whole blood is used for trauma resuscitation, more EMS facilities are shifting to administering blood products. The MaxPlus EMT Cooler from MaxQ is ideal for EMS facilities to carry blood and increase trauma patient survival rates.

The O2-MAX™ from Pulmodyne® Just Got Better

The O2-MAX™ from Pulmodyne® now includes an inhalation and exhalation filter providing 99.9992% bacterial and 99.997% viral efficiency.

A simple, effective solution to stop anterior epistaxis

A study concludes applying compression after administering tranexamic acid via a nasal atomizer effectively stops anterior epistaxis.

Simultaneously Deliver Oxygen and Nebulized Medications with a Filtered, Closed Mask Breathing System

The FLO2MAX is a filtered, closed oxygen mask with 99.99% filtration efficiency that can simultaneously delivery oxygen and nebulized medications.

Helping Emergency Personnel Provide High-Quality, Life-Saving Care

MED Alliance offers cost-effective, innovative products to support emergency personnel in providing high-quality, life-saving care.

Innovative Technologies from SCC Now Available on GPO Contracts

MED Alliance partner, Solutions in Critical Care (SCC), has been awarded group purchasing agreements for several innovative technologies.

A More Cost-Effective Nasal Mucosal Atomization Device

The new DART™ Nasal Device is a nasal mucosal atomization tool designed to deliver medications quickly and painlessly via the nasal passages. Comparable to competitive nasal devices, the DART™ is available at a fraction of the cost.

The DART-Reach™ from Pulmodyne – Targeted Administration of Atomized Medication

The DART-Reach™ is the latest technology from Pulmodyne® to aid anesthesia personnel. The laryngo-tracheal mucosal device allows providers to deliver misted atomized medication through a flexible stylet to the upper airway and vocal cords, even in the case of difficult airways.

REQUEST PRODUCT INFO

Med Alliance Group